Brian Concannon - 31 May 2024 Form 4 Insider Report for CONMED Corp (CNMD)

Role
Director
Signature
/s/ Thomas Fistek for Brian Concannon by Power of Attorney
Issuer symbol
CNMD
Transactions as of
31 May 2024
Net transactions value
$0
Form type
4
Filing time
05 Jun 2024, 09:33:12 UTC
Previous filing
08 Jun 2023
Next filing
04 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNMD Common Stock Options Exercise $0 +302 +3.2% $0.000000 9,637 31 May 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNMD Rsus (restricted Stock Units) Options Exercise $0 -302 -100% $0.000000* 0 31 May 2024 Common Stock 302 $0.000000 Direct F1
transaction CNMD Options To Purchase Common Stock Award $0 +5,503 $0.000000 5,503 03 Jun 2024 Common Stock 5,503 $77.18 Direct F2
transaction CNMD Rsus (restricted Stock Units) Award $0 +479 $0.000000 479 03 Jun 2024 Common Stock 479 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period.
F2 The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period.